Page 159 - Simplicity is Key in CRT

References
1. Bristow, M.R., et al., Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 2004. 350(21): p. 2140-50.
2. Cleland, J.G., et al., The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005. 352(15): p. 1539-49.
3. Ponikowski, P., et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Devel- oped with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016.
4. Ambrosy, A.P., et al., The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol, 2014. 63(12): p. 1123-33.
5. Boriani, G., et al., Cost-effectiveness of cardiac resynchronization therapy. Heart, 2012. 98(24): p. 1828-36.
6. Rohde, L.E., et al., Cost-effectiveness of heart failure therapies. Nat Rev Cardiol, 2013. 10(6): p. 338-54.
7. Brignole, M., et al., 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardi-
ac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the
European Heart Rhythm Association (EHRA). Eur Heart J, 2013. 34(29): p. 2281-329.
8. Tracy, C.M., et al., 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm
abnormalities: a report of the American College of Cardiology Foundation/A-merican Heart Association Task Force on Prac-
tice Guidelines and the Heart Rhythm Society. [corrected]. Circulation, 2012. 126(14): p. 1784-800.
9. Yancy, C.W., et al., 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation,
2013. 128(16): p. 1810-52.
10. Bogale, N., et al., The European cardiac resynchronization therapy survey: patient selection and implantation practice vary
according to centre volume. Europace, 2011. 13(10): p. 1445-53.
11. Marinskis, G., et al., Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm
Association survey. Europace, 2012. 14(3): p. 423-5.
12. Curtis, A.B., et al., Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J,
2009. 158(6): p. 956-64.
13. European Heart Rhythm, A., et al., 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in
heart failure: implant and follow-up recommendations and management. Heart Rhythm, 2012. 9(9): p. 1524-76.
14. Swedberg, K., et al., Successful treatment of heart failure with devices requires collaboration. Eur J Heart Fail, 2008.
10(12): p. 1229-35.
15. Tang, W.H., J. Boehmer, and D. Gras, Multispecialty approach: the need for heart failure disease management for refining
cardiac resynchronization therapy. Heart Rhythm, 2012. 9(8 Suppl): p. S45-50.
16. Singh, J.P., Electrical therapy for advanced heart failure: is it time for a multidisciplinary approach or a new subspecialty?
Expert Rev Cardiovasc Ther, 2007. 5(5): p. 811-5.
17. Rotter, T., et al., Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs.
Cochrane Database Syst Rev, 2010(3): p. CD006632.
18. De Bleser, L., et al., Defining pathways. J Nurs Manag, 2006. 14(7): p. 553-63.
19. Rotter, T., et al., The effects of clinical pathways on professional practice, patient outcomes, length of stay, and hospital
costs: Cochrane systematic review and meta-analysis. Eval Health Prof, 2012. 35(1): p. 3-27.
20. Vanhaecht, K., What about care pathways?, in Care of the Dying: A pathway to excellence. 2010, Oxford University Press:
Oxford.
21. G., Tennant., SIX SIGMA: SPC and TQM in manufactoring and Services. 2001: Gower Publishing, Ltd.
22. Martens, L., et al., Structured syncope care pathways based on lean six sigma methodology optimises resource use with
shorter time to diagnosis and increased diagnostic yield. PLoS One, 2014. 9(6): p. e100208.
23. Vanhaecht, K., et al., Do pathways lead to better organized care processes? J Eval Clin Pract, 2009. 15(5): p. 782-8.
24. Boriani, G., et al., Healthcare personnel resource burden related to in-clinic follow-up of cardiovascular implantable elec-
tronic devices: a European Heart Rhythm Association and Eucomed joint survey. Europace, 2011. 13(8): p. 1166-73.
25. Dickstein, K., et al., The European cardiac resynchronization therapy survey. Eur Heart J, 2009. 30(20): p. 2450-60.
26. Piccini, J.P., et al., Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation, 2008.
118(9): p. 926-33.
159